Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PAPacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc. (PACB)

NASDAQ Global Select · Currency in USD
$2.11 ▲ +0.05 (+2.43%)
At close: Oct 23, 4:00 PM ET. Market closed.
$2.09 ▼ -0.02 (-0.95%)
After hours: Oct 23, 7:57 PM ET

Summary

Previous Close
$2.06
Open
$2.02
Day's Range
$1.98 – $2.13
52 Week Range
$1.07 – $3.44
Volume
5,705,176
Avg. Volume
9,744,263
Market Cap
$655.85M
Beta (5Y Monthly)
2.19
PE Ratio (TTM)
--
EPS (TTM)
-$0.42
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$1.93

Profile: Pacific Biosciences of California, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
485
CEO
Mark Van Oene
Website
pacb.com

Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are essential consumable products, such as their unique single molecule real-time (SMRT) cells.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate -$0.13 · Revenue est. $43.82M
DateEst.Actual
Aug 3, 2026-$0.13-$0.14Miss
May 7, 2026-$0.17-$0.03Beat
Feb 12, 2026-$0.19-$0.12Beat
Nov 5, 2025-$0.16-$0.12Beat
Aug 7, 2025-$0.18-$0.13Beat
May 8, 2025-$0.19-$1.44Miss

Analyst view

Consensus price target
$1.93 ▼ -8.5%
Range $1.35 – $2.50
Rating: Buy
Buy 50% · Hold 44% · Sell 6%

Similar stocks

Get free alerts on PACB and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.